Anti-MALRD1 monoclonal antibody

Pre-made anti-MALRD1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to MALRD1/MALRD1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1138-Ab-1/ GM-Tg-hg-IP1138-Ab-2Anti-Human MALRD1 monoclonal antibodyHuman
GM-Tg-rg-IP1138-Ab-1/ GM-Tg-rg-IP1138-Ab-2Anti-Rat MALRD1 monoclonal antibodyRat
GM-Tg-mg-IP1138-Ab-1/ GM-Tg-mg-IP1138-Ab-2Anti-Mouse MALRD1 monoclonal antibodyMouse
GM-Tg-cynog-IP1138-Ab-1/ GM-Tg-cynog-IP1138-Ab-2Anti-Cynomolgus/ Rhesus macaque MALRD1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1138-Ab-1/ GM-Tg-felg-IP1138-Ab-2Anti-Feline MALRD1 monoclonal antibodyFeline
GM-Tg-cang-IP1138-Ab-1/ GM-Tg-cang-IP1138-Ab-2Anti-Canine MALRD1 monoclonal antibodyCanine
GM-Tg-bovg-IP1138-Ab-1/ GM-Tg-bovg-IP1138-Ab-2Anti-Bovine MALRD1 monoclonal antibodyBovine
GM-Tg-equg-IP1138-Ab-1/ GM-Tg-equg-IP1138-Ab-2Anti-Equine MALRD1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1138-Ab-1/ GM-Tg-hg-IP1138-Ab-2; GM-Tg-rg-IP1138-Ab-1/ GM-Tg-rg-IP1138-Ab-2;
GM-Tg-mg-IP1138-Ab-1/ GM-Tg-mg-IP1138-Ab-2; GM-Tg-cynog-IP1138-Ab-1/ GM-Tg-cynog-IP1138-Ab-2;
GM-Tg-felg-IP1138-Ab-1/ GM-Tg-felg-IP1138-Ab-2; GM-Tg-cang-IP1138-Ab-1/ GM-Tg-cang-IP1138-Ab-2;
GM-Tg-bovg-IP1138-Ab-1/ GM-Tg-bovg-IP1138-Ab-2; GM-Tg-equg-IP1138-Ab-1/ GM-Tg-equg-IP1138-Ab-2
Products NameAnti-MALRD1 monoclonal antibody
Formatmab
Target NameMALRD1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-MALRD1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1138-Ag-1Recombinant multi-species MALR1/ MALRD1/ C10orf112 protein


    Target information

    Target IDGM-IP1138
    Target NameMALRD1
    Gene ID340895,102635496,100361092,706887,119871067,101080548,783682,100146768
    Gene Symbol and SynonymsbA265G8.2,C10orf112,DIET1,Gm13318,Gm13364,MALRD1,RGD1559888,RGD1563652
    Uniprot AccessionQ5VYJ5
    Uniprot Entry NameMALR1_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000204740
    Target ClassificationN/A

    The target: MALRD1, gene name: MALRD1, also named as C10orf112, DIET1, bA265G8.2. This gene encodes a conserved protein that features multiple MAM (meprin-A5-protein tyrosine phosphatase mu) and LDLR A2 (low density lipoprotein receptor A2) domains. Expression of this gene is enriched in the small intestine and is upregulated during differentiation of a human cell line that exhibits properties of intestinal epithelial cells. The encoded protein has been shown to modulate production of FGF19 in a human intestinal cell line and may regulate bile acid metabolism in the liver. A synergistic interaction between an allele of this gene and the APOE E4 allele is associated with an elevated risk of Alzheimer's disease in human patients. [provided by RefSeq, Jul 2017].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.